Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.
Department of Respiratory and Critical Care Medicine, Ganzhou People's Hospital, Ganzhou 341000, China.
Exp Biol Med (Maywood). 2023 Sep;248(18):1579-1587. doi: 10.1177/15353702231191205. Epub 2023 Oct 3.
Non-invasive positive-pressure ventilation (NIPPV) has been demonstrated to exhibit a cardioprotective function in a rat model of myocardial infarction (MI). However, the mechanism underlying NIPPV-mediated MI progression requires further investigation. We aimed to investigate the effectiveness and corresponding mechanism of NIPPV in an acute MI-induced heart failure (HF) rat model. Thirty each of healthy wild type (WT) and apoptosis signal-regulating kinase 1 (ASK-1)-deficient rats were enrolled in this study. MI models were established via anterior descending branch ligation of the left coronary artery. The corresponding data indicated that NIPPV treatment reduced the heart infarct area, myocardial fibrosis degree, and cardiac function loss in MI rats, and ameliorated apoptosis and reactive oxygen species (ROS) levels in the heart tissue. Furthermore, the expression level of ASK-1 level, a key modulator of the ROS-induced extrinsic apoptosis pathway, was upregulated in the heart tissues of MI rats, but decreased after NIPPV treatment. Meanwhile, the downstream cleavage of caspase-3, caspase-9, and PARP, alongside p38 phosphorylation and FasL expression, exhibited a similar trend to that of ASK-1 expression. The involvement of ASK-1 in NIPPV-treated MI in ASK-1-deficient rats was examined. Although MI modeling indicated that cardiac function loss was alleviated in ASK-1-deficient rats, NIPPV treatment did not confer any clear efficiency in cardiac improvement in ASK-1-knockdown rats with MI modeling. Nonetheless, NIPPV inhibited ROS-induced extrinsic apoptosis in the heart tissues of rats with MI by regulating ASK-1 expression, and subsequently ameliorated cardiac function loss and MI-dependent pathogenic changes in the heart tissue.
无创正压通气(NIPPV)已被证明在心肌梗死(MI)大鼠模型中具有心脏保护作用。然而,NIPPV 介导的 MI 进展的机制仍需要进一步研究。我们旨在研究 NIPPV 在急性 MI 诱导的心衰(HF)大鼠模型中的有效性及其相应机制。本研究纳入了 30 只健康野生型(WT)和凋亡信号调节激酶 1(ASK-1)缺陷型大鼠。通过结扎左冠状动脉前降支建立 MI 模型。相应的数据表明,NIPPV 治疗可减少 MI 大鼠的心肌梗死面积、心肌纤维化程度和心功能丧失,并改善心脏组织中的细胞凋亡和活性氧(ROS)水平。此外,ASK-1 水平作为 ROS 诱导的细胞外凋亡途径的关键调节剂,在 MI 大鼠的心脏组织中表达上调,但在 NIPPV 治疗后下调。同时,caspase-3、caspase-9 和 PARP 的下游裂解,以及 p38 磷酸化和 FasL 表达,与 ASK-1 表达呈相似趋势。我们还研究了 ASK-1 在 NIPPV 治疗 MI 中的作用。尽管 MI 模型表明 ASK-1 缺陷型大鼠的心脏功能丧失得到缓解,但在 MI 建模的 ASK-1 敲低大鼠中,NIPPV 治疗并未明显改善心脏改善。然而,NIPPV 通过调节 ASK-1 表达抑制 MI 大鼠心脏组织中的 ROS 诱导的细胞外凋亡,从而改善心脏功能丧失和 MI 相关的心脏组织病理变化。